These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12796417)

  • 1. Chlamydia pneumoniae, antibiotic treatment, and early atherosclerosis.
    Liuba P; Pesonen E; Paakkari I
    Circulation; 2003 Jun; 107(22):e205; author reply e205. PubMed ID: 12796417
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced progression of early carotid atherosclerosis after antibiotic treatment and Chlamydia pneumoniae seropositivity.
    Sander D; Winbeck K; Klingelhöfer J; Etgen T; Conrad B
    Circulation; 2002 Nov; 106(19):2428-33. PubMed ID: 12417538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlamydia pneumoniae-atherosclerosis link: a sound concept in search for clinical relevance.
    Neumann FJ
    Circulation; 2002 Nov; 106(19):2414-6. PubMed ID: 12417534
    [No Abstract]   [Full Text] [Related]  

  • 4. Treating Chlamydia pneumoniae in patients with early atherosclerosis.
    SoRelle R
    Circulation; 2002 Nov; 106(19):e9047-8. PubMed ID: 12417556
    [No Abstract]   [Full Text] [Related]  

  • 5. Progression of peripheral arterial occlusive disease is associated with Chlamydia pneumoniae seropositivity and can be inhibited by antibiotic treatment.
    Krayenbuehl PA; Wiesli P; Maly FE; Vetter W; Schulthess G
    Atherosclerosis; 2005 Mar; 179(1):103-10. PubMed ID: 15721015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: a randomized, double-blind, placebo-controlled trial.
    Wiesli P; Czerwenka W; Meniconi A; Maly FE; Hoffmann U; Vetter W; Schulthess G
    Circulation; 2002 Jun; 105(22):2646-52. PubMed ID: 12045171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlamydia pneumoniae eradication from carotid plaques. Results of an open, randomised treatment study.
    Melissano G; Blasi F; Esposito G; Tarsia P; Dordoni L; Arosio C; Tshomba Y; Fagetti L; Allegra L; Chiesa R
    Eur J Vasc Endovasc Surg; 1999 Oct; 18(4):355-9. PubMed ID: 10550273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae.
    Black PN; Blasi F; Jenkins CR; Scicchitano R; Mills GD; Rubinfeld AR; Ruffin RE; Mullins PR; Dangain J; Cooper BC; David DB; Allegra L
    Am J Respir Crit Care Med; 2001 Aug; 164(4):536-41. PubMed ID: 11520711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of early carotid atherosclerosis is only temporarily reduced after antibiotic treatment of Chlamydia pneumoniae seropositivity.
    Sander D; Winbeck K; Klingelhöfer J; Etgen T; Conrad B
    Circulation; 2004 Mar; 109(8):1010-5. PubMed ID: 14769704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarction. Results from a sub-study of the randomised Antibiotic Therapy in Acute Myocardial Infarction (ANTIBIO) trial.
    Burkhardt U; Zahn R; Höffler U; Siegler KE; Frilling B; Weber M; Gottwik M; Wehr M; Seidel F; Rosocha S; Tebbe U; Senges J
    Z Kardiol; 2004 Sep; 93(9):671-8. PubMed ID: 15365734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial.
    Neumann F; Kastrati A; Miethke T; Pogatsa-Murray G; Mehilli J; Valina C; Jogethaei N; da Costa CP; Wagner H; Schömig A
    Lancet; 2001 Jun; 357(9274):2085-9. PubMed ID: 11445102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae.
    Rothstein NM; Quinn TC; Madico G; Gaydos CA; Lowenstein CJ
    J Infect Dis; 2001 Jan; 183(2):232-238. PubMed ID: 11120929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of roxithromycin treatment on the endothelial function of Chlamydia pneumoniae seropositive men suffering from peripheral arterial occlusive disease.
    Wiesli P; Schulthess G
    Circulation; 2002 Dec; 106(25):e226; author reply e226. PubMed ID: 12485976
    [No Abstract]   [Full Text] [Related]  

  • 14. [Percentage of asthmatic patients with acute bronchitis and Chlamydia pneumoniae seropositivity].
    Orfila J; Godard P
    Presse Med; 2000 Sep; 29(25):1439-41. PubMed ID: 11036523
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of IgG-seropositivity to Chlamydia pneumoniae in early thrombotic events after coronary stent placement.
    da Costa CP; Neumann FJ; Kastrati A; Stallforth I; Schmid M; Joghetai N; Prebeck S; Wagner H; Miethke T
    Atherosclerosis; 2003 Jan; 166(1):171-6. PubMed ID: 12482564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early carotid atherosclerosis and Chlamydia pneumoniae seropositivity: are there arguments to treat with antibiotics?
    Ieven MM; Hoymans VY; Bosmans JM
    Circulation; 2004 Aug; 110(7):e74-5; author reply e74-5. PubMed ID: 15313965
    [No Abstract]   [Full Text] [Related]  

  • 17. Chlamydia pneumoniae infections in mouse models: relevance for atherosclerosis research.
    de Kruif MD; van Gorp EC; Keller TT; Ossewaarde JM; ten Cate H
    Cardiovasc Res; 2005 Feb; 65(2):317-27. PubMed ID: 15639470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cough syncope caused by a possible Chlamydia pneumoniae pneumonia].
    Cinotti R; Moubarak G; Gervais R; Mabo P
    Rev Med Interne; 2009 Sep; 30(9):809-11. PubMed ID: 19586690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotics and coronary heart disease.
    Modest GA; Kaufmann J
    JAMA; 2004 Jan; 291(3):302; author reply 303. PubMed ID: 14734586
    [No Abstract]   [Full Text] [Related]  

  • 20. Roxithromycin in prevention of acute coronary syndrome associated with Chlamydia pneumoniae infection: a randomized placebo controlled trial.
    Leowattana W; Bhuripanyo K; Singhaviranon L; Akaniroj S; Mahanonda N; Samranthin M; Pokum S
    J Med Assoc Thai; 2001 Dec; 84 Suppl 3():S669-75. PubMed ID: 12002908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.